Free Trial
LON:CREO

Creo Medical Group (CREO) Share Price, News & Analysis

Creo Medical Group logo
GBX 13.17 +0.24 (+1.89%)
As of 07:56 AM Eastern

About Creo Medical Group Stock (LON:CREO)

Key Stats

Today's Range
12.75
13.22
50-Day Range
12.25
15.81
52-Week Range
9.22
37
Volume
255,784 shs
Average Volume
1.16 million shs
Market Capitalization
£53.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CREO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Creo Medical Group and its competitors with MarketBeat's FREE daily newsletter.

CREO Stock News Headlines

Former CIA Officer Reveals How Gold Saved His Life
This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained to stay alive when systems collapse. In Operation Gold Rush, Jason Hanson reveals how gold and silver saved his life—and how they could protect yours in the next crisis. You’ll learn how to hide gold like a covert operative, secure your 401(k) in physical assets, and prepare for grid failures, economic collapse, or worse.
Creo Medical Updates Shareholder Notification
See More Headlines

CREO Stock Analysis - Frequently Asked Questions

Creo Medical Group's stock was trading at GBX 20.40 at the beginning of 2025. Since then, CREO stock has decreased by 35.5% and is now trading at GBX 13.17.

Creo Medical Group PLC (LON:CREO) released its quarterly earnings results on Monday, May, 19th. The company reported ($8.00) earnings per share (EPS) for the quarter. Creo Medical Group had a negative trailing twelve-month return on equity of 41.79% and a negative net margin of 73.93%.

Shares of CREO stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Creo Medical Group investors own include Aviva (AV), IQE (IQE), Lloyds Banking Group (LLOY), Barclays (BARC), BP (BP), BT Group (BT.A) and Coats Group (COA).

Company Calendar

Last Earnings
5/19/2025
Today
8/10/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
LON:CREO
CIK
N/A
Fax
N/A
Employees
279
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (6.32)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£25.04 million
Net Margins
-73.93%
Pretax Margin
N/A
Return on Equity
-41.79%
Return on Assets
-20.09%

Debt

Debt-to-Equity Ratio
29.96
Current Ratio
3.24
Quick Ratio
2.19

Sales & Book Value

Annual Sales
£33.87 million
Price / Sales
1.54
Cash Flow
GBX 5.32 per share
Price / Cash Flow
2.43
Book Value
GBX 13.11 per share
Price / Book
0.99

Miscellaneous

Outstanding Shares
404,265,846
Free Float
N/A
Market Cap
£52.26 million
Optionable
Not Optionable
Beta
0.86
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (LON:CREO) was last updated on 8/11/2025 by MarketBeat.com Staff
From Our Partners